Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Colon cleansing compositions and methods

a technology of compositions and colons, applied in the field of colon evacuants or colon cleansing compositions, orthostatic lavage solutions, can solve the problems of time-consuming dietary manipulation and laxatives, unpleasant enemas for patients, and various drawbacks of methods

Inactive Publication Date: 2007-05-24
NORGINE BV
View PDF6 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0111] Furthermore, the composition of the invention was better accepted than PEG+E, which acceptance is related to the improved taste and lower volume to be taken. In addition, NRL994 was shown to be as safe as PEG+E in a patient group that is enhanced for risk factors (hospitalised patients). Moreover, the comparison with NaP indicated an improved safety profile for the composition of the invention without clinically significant electrolyte alterations or disturbances. Overall, the composition of the invention provides an effective and safe bowel cleansing procedure with patient compliance equivalent to that with NaP. Furthermore, the composition of the invention avoids the need to limit its use to younger and more healthy subjects undergoing a routine colonoscopy, as required by NaP.
[0112] Accordingly, a composition of the present invention may be used to treat patient populations for which PEG+E or especially, NaP, would be considered unsuitable or unsafe; for example, outpatients, young and old patients, and patients having clinical conditions that would make them unsuitable for treatment, especially with NaP.

Problems solved by technology

Those methods suffer from various drawbacks.
Dietary manipulation and laxatives are time consuming; enemas are unpleasant for the patient; and dangerous salt and water losses may occur with cathartics, enemas and with sodium phosphate solutions.
If the water is not taken, elevated serum sodium and phosphate levels may result, leading to serious kidney problems.
The risk of those side effects makes it necessary for there to be direct medical supervision during administration of Phospho-soda.
Consumption of the solution results in volume-induced diarrhoea and thus cleansing of the colon.
However, as a significant percentage of such saline-based lavage solutions is absorbed into the bloodstream in the gut of the patient, a rapid increase in intravascular volume results, which has caused serious complications in some patients.
The GoLYTELY solution, whilst effective, has a very salty taste, which adversely affects patient compliance.
Consumption of such large volumes of fluid can also affect compliance adversely.
Ingestion of such volumes of gut lavage solution is generally physically unpleasant or even impossible for many patients, may result in retching, and is time consuming.
The unpleasant taste exacerbates the problem of patient compliance, particularly when the patient is not under medical supervision.
Ingestion of such volumes of gut lavage solution is still generally physically unpleasant or, for some patients, even impossible, may result in retching, and is time consuming.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

Comparison of Effectiveness of 2-Litre Solutions of Movicol, Movicol+Ascorbic Acid and Movicol+Ascorbic Acid+Sodium Sulphate

[0113] 6 healthy volunteers were given a 2 litre dose of each of A) Movicol, B) Movicol+ascorbic acid and C) Movicol+ascorbic acid+sodium sulphate and the volume of stools produced was measured. Movicol is a registered trademark of Norgine Limited and it is used in connection with a product of the formulation given in Table 2 below. The trial was carried out as a double blind cross-over study with 2 running periods for formulations A and B. Each volunteer was given formulation A and formulation B once each in a random order. The volunteers and the administering medical professional were blinded regarding which formulation was administered first. A third, open, study period was added for the investigation of formulation C. The composition of Movicol is shown in Table 2. The compositions of the three formulations are shown in Table 3.

TABLE 2Composition per lit...

example 2

Comparison of Compositions of the Invention

[0125] A trial was carried out to investigate the effect on the efficacy of the cleansing solutions of the invention of altering, independently, the quantities of the PEG, sodium sulphate and ascorbic acid components. Six compositions were investigated. The formulations were made up as aqueous solutions comprising compositions, A to F. The amount of each component in compositions A to F per litre of formulation is shown in Table 6.

TABLE 6Compositions A to F of the inventionIngredient (g)SodiumSodiumOsmolarityComp.PEG 3350SulphateAscorbic AcidAscorbateNaClKClmOsmol / kgA1007.50.00.02.6911.058308B1007.55.00.02.6911.058337C1007.55.05.02.6911.058379D1007.510.00.02.6911.058365E1005.05.05.02.6910.819329F1257.55.05.03.2171.155416

NB All compositions were lemon flavoured. The lemon flavouring was Ungerer Lemon SDF obtained from RSSL Pharma.

[0126] Composition E (containing 100 g PEG, 5 g sodium sulphate, 5 g ascorbic acid, 5 g sodium ascorbate, el...

example 3

Study of Ingestion of Colon Cleansing Composition Interspersed with Water Ingestion

[0163] Ten subjects were enrolled for the study and written informed consent was given before its commencement. Each volunteer was given 2 litres of composition D as defined in Example 2. The composition was administered according to two different modes of administration on two different occasions separated by a wash-out period. In administration mode 1, the volunteer drank 2 litres of composition D within 2 hours as in the case of Example 2. According to administration mode 2 the volunteer drank 1 litre of composition over 1 hour, followed by 500 ml water over the next hour, followed by a second litre of composition over the following hour, followed by 1000 ml water over the following 2 hours.

[0164] Stools were collected over the 8 hours following commencement of the administration. A comparison of stool weights obtained by the two modes of administration is shown in Table 21.

TABLE 21Comparison o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A composition comprising, per litre of aqueous solution, from 30 to 350 g polyethylene glycol, from 3 to 20 g of an ascorbic acid component selected form the group consisting of ascorbic acid, a salt of ascorbic acid, or a mixture thereof, an alkali metal or alkaline earth metal sulphate, preferably from 1 to 15 g thereof, and optionally one or more electrolytes selected from sodium chloride, potassium chloride, and sodium hydrogen carbonate, and preferably also comprising flavourings, is effective in cleansing the gut in preparation for a endoscopy, especially colonoscopy. It is safer than conventional sodium phosphate-based gut cleansing compositions, and hence can be used for patients who would be at risk with sodium phosphate-based compositions, and is better tolerated than conventional PEG-based compositions, leading to better patient compliance and enabling effective out-patient use.

Description

[0001] The present application claims priority to co-pending British application number GB 0224909.2, filed Oct. 25, 2002, the disclosure of which application is specifically incorporated herein by reference without disclaimer. FIELD OF THE INVENTION [0002] The present invention relates to orthostatic lavage solutions, colon evacuants or colon cleansing compositions, also known as lavage compositions for cleansing the gastrointestinal tract, and methods of use of such compositions. GENERAL BACKGROUND [0003] Colon cleansing is important prior to numerous diagnostic and surgical procedures, for example before colonoscopy, barium enema examination or colon surgery. It is also useful for preventing infection after surgery on the lower intestine. Colon cleansing is also known as colon clearing. [0004] A variety of methods for colon cleansing are known. Dietary manipulation, laxatives, cathartics and enemas were traditionally used (Thomas, G. et al., Gastroenterology, 1982, 82, 435-437). ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/765A61K33/00A61K31/375A61K9/00A61K33/04A61K33/06A61K33/14A61K47/00
CPCA61K9/009A61K9/0095A61K31/375A61K31/765A61K33/00Y10S514/892A61K33/06A61K33/14A61K45/06A61K33/04A61K2300/00A61P1/00A61P1/10A61P31/00A61K9/08A61K47/02A61K47/22
Inventor BARRAS, NORMANCOX, IAN DAVID
Owner NORGINE BV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products